11 – 20 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles.
(
- Contribution to journal › Article
- 2014
-
Mark
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy.
(
- Contribution to journal › Article
-
Mark
Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response
(
- Contribution to journal › Article
- 2013
-
Mark
Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy.
(
- Contribution to journal › Article
- 2012
-
Mark
A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
(
- Contribution to journal › Article
- 2011
-
Mark
Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
(
- Contribution to journal › Article
-
Mark
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2009
-
Mark
A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
(
- Contribution to journal › Article